Pretreatment with propranolol was shown to protect against postischemic brain infarction, edema, and apoptosis; the neuroprotection caused by propranolol was accompanied by a reduction in plasma c-reactive protein, plasma free fatty acids, plasma corticosterone, brain oxidative stress, and brain inflammation [182]. The gene discussed is CRP; the disease is brain inflammatory disease.